Johnson & Johnson (JNJ) discloses updated portfolio positions in 13F filing: Maintains most holdings, Lowered RAPP (195.40 +1.02)
Highlights from Q3 2025 filing as compared to Q2 2025 (all amounts are approximate):
- Maintained: MGTX (from 6.6 mln shares), NBTX (5.6 mln), CVRX (4.1 mln), RLYB (3.6 mln), FATE (3.4 mln), PTGX (2.5 mln), CTNM (2 mln), NMRA (1.9 mln), LEGN (815K), XNCR (748K), ACET (364K), PRCT (358K), LAB (312K), ARWR (248K), NNOX (159K), PHGE (97K), SENS (55K), VOR (54K - split adjusted), LYEL (41K)
- Decreased: RAPP (1.78 mln shares from 2.5 mln shares)